Home | Welcome to Contract Pharma   
Last Updated Saturday, November 22 2014
Print

Topics - APIs


Refine by Date:
From: To:
Published November 21, 2014
Expands capacity for immunology and oncology pipelines Read More »
Published November 17, 2014
Warburg Pincus invests $92mn in the Indian maker of APIs. Read More »
Published October 21, 2014
Expands drug development and bioavailability capabilities Read More »
Published October 15, 2014
Increasing GMP issues may threaten patient safety unless QbD adoption grows Read More »
Published October 13, 2014
Will offer newly developed galenic forms Read More »
Published October 2, 2014
Aims to develop scalable and cost-effective process for a targeted API Read More »
Published September 4, 2014
Complies with the quality GMP & GDP standards Read More »
Published August 20, 2014
Expands geographic scale, manufacturing and lyophilization capabilities Read More »
Published August 18, 2014
To manufacture API for branded commercial drug Read More »
Published August 5, 2014
Ireland facility gains pre-approval Read More »
Published July 22, 2014
Will support a portfolio of drug substance campaigns Read More »
Published July 22, 2014
Will produce NME for U.S. market Read More »
Published July 21, 2014
Phase IIa trial scheduled for 2014 Read More »
Published June 23, 2014
Expands GMP manufacturing services for APIs Read More »
Published May 20, 2014
Secures additional manufacturing capacity for Patiromer Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On